Andy Smith
Andy Smith founded NewMed and CELLER8 and hosts The PEMF Podcast, drawing on more than a decade selling and developing pulsed electromagnetic field technology
At a glance
- Current work
Current first-party company records
- Public platform
- Host of The PEMF Podcast, a commercial education channel connected to NewMed and CELLER8The PEMF Podcast
Current podcast and company pages
- Product development
- CELLER8 was developed with Bedfont ScientificBedfont Scientific
Bedfont launch announcement
- Profile lane
- Expert & Voice — founder, device operator and educator
Public role; no clinical credential asserted
About
Andy Smith founded NewMed after his own experience with a PEMF mat following surgery. NewMed began selling several PEMF systems in 2014, giving Smith a decade of direct exposure to the questions consumers and practitioners ask about the technology.
He later led a six-year development process for CELLER8 with Bedfont Scientific. The brand launched publicly in 2023 and expanded with a CELLER8 Max system in 2025. Smith now combines company leadership with interviews and technical explainers through The PEMF Podcast.
Companies and platforms around the work
- Leadership and company relationships (CELLER8)
- Founder · chief executive officer
- Founder and chief executive of CELLER8.
- Operating company
- NewMed — founder and managing director; established as a dedicated company in 2017 after operating as a division from 2014NewMed
NewMed company history
- Manufacturing relationship
- Bedfont Scientific manufactures CELLER8; NewMed was named its global exclusive distributor at launchBedfont Scientific
Bedfont launch announcement
- Co-founder
- Jade Emmerton-Smith is identified by CELLER8 as co-founder and brand manager
Current CELLER8 team page
Topics across his public work
Themes documented across Smith's podcast, company interviews and product-development record.
How the public role developed
2012 · first-person account
Smith attributes his interest in PEMF to his own post-surgical recovery; that origin story is personal testimony, not a clinical study.
Introduced 2014 · incorporated as a dedicated company in 2017
The business distributed several PEMF systems before CELLER8 became its flagship consumer brand.
Six-year design process · public launch 2023
Bedfont Scientific supplied manufacturing expertise while NewMed held the launch distribution role.
Host · interviews and technical explainers
The show covers the broader PEMF field while also directing listeners to products and businesses connected to Smith.
Selected interviews and company records
These sources document Smith's roles, operating experience and attributed views. They do not independently establish the health effects claimed for a particular device.
The PEMF Podcast · episode 100 · 2026
A retrospective on Smith's commercial experience, product specifications and the development of CELLER8
Apple Podcasts · 2026
A long-form guest interview about Smith's company path and view of consumer PEMF technology
Bedfont Scientific · June 2023
The manufacturer's launch record naming NewMed as global exclusive distributor and Smith as managing director
NewMed · December 2025
A first-party account of the operating company's closer alignment with CELLER8 and Smith's education strategy
Where to follow the current work
Company timeline, team and Smith's account of the brand's origin
Current episodes and interviews hosted by Smith
Company explainers, episode transcripts and announcements
Current professional identity and company updates
Links
public work
public_work
Elsewhere
Media and talks
- Apple Podcasts
- vP life / vitalityPRO · 2024-08
- The Wellness Way · 2025-10
- The PEMF Podcast · 2026-08
- Thyroid Pharmacist Healing Conversations with Dr. Izabella Wentz · 2026-08
- Dave Asprey’s Beyond Biohacking Conference
Profiles
What to consider
This is a founder and public-work profile, not a clinical-practice listing. Smith's experience comes from developing, distributing and explaining PEMF products; it is not a medical qualification or an independent assessment of the products his companies sell.
Reading founder experience and product evidence clearly
Smith's public authority comes from selling, developing and explaining PEMF devices. His companies sell the products he discusses, and The PEMF Podcast links directly to those commercial routes.
His recovery story helps explain why he entered the category, but it cannot predict another person's outcome. The most useful next step is to separate general PEMF research from evidence for the exact device, settings and intended use under consideration.
Transparency and sources
Smith's identity, founder roles, company timeline, manufacturing relationship and podcast were checked across current first-party and manufacturing records.
Reviewed
Founder roles, company history and public work checked
Current CELLER8 and NewMed records, the manufacturing launch record and the podcast were reviewed separately.
Corrections or current-role updates can be submitted through Longevity.io's standard editorial contact route.
Researched by Longevity.io
- First-party founder, team and company timeline
- First-party company origin and operating history
- Manufacturer launch and distribution record
- Current public-work and commercial-link record
- Current first-person professional identity
Verification
- Profile updated
- Credentials checked
- Affiliations verified
Primary sourcehttps://celler8.com/pages/about-us
Where a detail is missing, it means we have not verified it—not that the answer is no. Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.